9SO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Solasia Pharma KK engages in the development, sale, import and export of pharmaceutical products and medical devices. It provides patients access to western oncology and hematology therapies by developing products licensed from western pharmaceutical and biotechnology companies. The company was founded by Bard Geesaman, John McDonald, and Koji Shinozaki in December 2006 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
9SO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company